Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Catalyst Pharmaceuticals (CPRX) Accumulated Depreciation & Amortization: 2012-2025

Historic Accumulated Depreciation & Amortization for Catalyst Pharmaceuticals (CPRX) over the last 12 years, with Sep 2025 value amounting to -$1,000.

  • Catalyst Pharmaceuticals' Accumulated Depreciation & Amortization rose 99.74% to -$1,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$567,000, marking a year-over-year increase of 50.52%. This contributed to the annual value of -$304,000 for FY2024, which is 49.02% down from last year.
  • Catalyst Pharmaceuticals' Accumulated Depreciation & Amortization amounted to -$1,000 in Q3 2025, which was up 98.63% from -$73,000 recorded in Q2 2025.
  • Catalyst Pharmaceuticals' 5-year Accumulated Depreciation & Amortization high stood at $133,000 for Q4 2022, and its period low was -$389,000 during Q3 2024.
  • Moreover, its 3-year median value for Accumulated Depreciation & Amortization was -$223,000 (2023), whereas its average is -$222,455.
  • Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first spiked by 1,200.00% in 2022, then slumped by 654.55% in 2023.
  • Over the past 5 years, Catalyst Pharmaceuticals' Accumulated Depreciation & Amortization (Quarterly) stood at $21,000 in 2021, then surged by 533.33% to $133,000 in 2022, then plummeted by 253.38% to -$204,000 in 2023, then crashed by 49.02% to -$304,000 in 2024, then soared by 99.74% to -$1,000 in 2025.
  • Its Accumulated Depreciation & Amortization stands at -$1,000 for Q3 2025, versus -$73,000 for Q2 2025 and -$189,000 for Q1 2025.